←
Trisha2,041 posts
Trisha avatar

Trisha

@TrishaReads8
◷ Joined November 2022▧ 286 Photos and videos
Stiff Person Syndrome Research Foundation avatar
⟳ Trisha retweeted
Stiff Person Syndrome Research Foundation@TheSPSRF·Nov 17

Kyverna has completed its BLA submission to the FDA for miv-cel, its investigational therapy for stiff person syndrome, and requested Priority Review. The FDA will now decide whether to accept it. Miv-cel isn’t FDA-approved.

Post attachment
Lupus Europe avatar
⟳ Trisha retweeted
Lupus Europe@LupusEurope·Nov 11

AI, health inequalities and EU policy were on the agenda at EULAR PARE Conference in Brussels. Proud to take part, with @Jeanette_Lupus, Chair of the Lupus Europe Board, presenting #LupusGPT & the role of patient organisations in shaping responsible AI. Thanks @eular_org PARE!

Post attachment
BIDMC_Rheumatology avatar
⟳ Trisha retweeted
BIDMC_Rheumatology@BIDMC_Rheum·Nov 10

CAR-T therapy for autoimmune diseases: Are we ready? Dr. George Tsokos, Chief of Rheumatology at BIDMC, presented the “Not Yet” perspective at #ACR26, highlighting the promise, pitfalls, and risks of premature enthusiasm for CAR-T therapy in autoimmunity.

Post attachmentPost attachment
Trisha avatar
Trisha@TrishaReads8·Nov 10

Thanks to our friends at @IAFaccess for providing this patient-reviewed product. I’ve already reached out for info to purchase the purple 💜 for home infusion. #lupus @LADAOrg

Huge thanks to Spongies for being such an amazing partner! 🙌 Our Champion Nya tested their products, and she loved them. We’re so excited to keep highlighting infusion-related products that genuinely support our community.

0:50
Lupus Association avatar
⟳ Trisha retweeted
Lupus Association@LADAOrg·Nov 10

Treasury's proposed COINS Act rule would cut U.S. companies off from biotech research abroad, and from breakthroughs people with lupus are counting on. National security matters, but medical R&D isn't a threat. It's hope. Protect Americans’ access to cures.

NYU Grossman School of Medicine avatar
⟳ Trisha retweeted
NYU Grossman School of Medicine@nyugrossman·Nov 8

A lab test that stresses a patient’s own immune cells may predict who will respond to TNF inhibitors for psoriatic arthritis and IBD. Early data from @NYULangone at #ACR26. ⤵️

1:59
Dr.Mukesh , MD , DM avatar
⟳ Trisha retweeted
Dr.Mukesh , MD , DM@dr_immuno29·Nov 8

Same lupus. Different immune biology. Beyond anti-dsDNA and complement—#ACR26 insights: • Tph cells and atypical B cells expand in SLE, linking T–B cell activation with flares. • Blood profiling identifies 3 lupus nephritis groups: immunologically inactive, IFN-high and cytotoxic T-cell dominant—with differing renal pathology and treatment responses. • IFN signatures/SIGLEC-1 can track pathway suppression after anifrolumab. The next frontier: matching treatment to immune biology. Promising; biomarker-guided prescribing still needs validation. Credit: Dr Deepak Rao #ACRAmbassador #Lupus #LupusNephritis #PrecisionMedicine

Post attachmentPost attachmentPost attachmentPost attachment
Trisha avatar
Trisha@TrishaReads8·Nov 8

Cheering extra loud for members of #BostonRheumRoyalty - congrats! #ACR26 💜

Happening now at #ACR26! 🔬 Our BIDMC Rheumatology fellow Dr. Ryan Payne is presenting his research on treatment patterns, hematologic response, and glucocorticoid exposure in SLE-associated hemolytic anemia! 📍 Poster 0250 | Hall WB1&2 Stop by and say hello! 👏

Post attachmentPost attachment